Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation
Identifieur interne : 000921 ( Main/Corpus ); précédent : 000920; suivant : 000922Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation
Auteurs : Ken-Jiroh Miyamoto ; Kazufumi Tsuchihashi ; Kikuya Uno ; Shin-Ya Shimoshige ; Nobuhiro Yoshioka ; Atsushi Doi ; Tomoaki Nakata ; Kazuaki ShimamotoSource :
- Pacing and Clinical Electrophysiology [ 0147-8389 ] ; 2001-06.
English descriptors
- KwdEn :
Abstract
MIYAMOTO, K.‐J., et al.: Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation. Atrial flutter and AF are complications in approximately 30% of cases of paroxysmal supraventricular tachycardia (PSVT)‐indicated catheter ablation, and it is of interest to determine if therapeutic modification for PSVT would eliminate combined atrial tachyarrhythmia like atrial flutter and AF. The aim of this study was to determine the incidence and the risk of atrial tachyarrhythmias after catheter ablation of PSVT. A total of 152 patients (age range 12–74, mean 41 ± 17 years) with accessory pathway (n = 106) and/or dual atrioventricular nodal conduction (n = 46) were enrolled in a 2‐year follow‐up program after successful catheter ablation. Possible risks on clinical background (age, sex, PSVT duration, hemodynamic instability during attacks), premature atrial contraction (PACs) on Holter monitoring, echocardiographic left atrial size, and electrophysiological property (insertion site, conduction type, effective refractory period) were evaluated. Atrial flutter and AF were complications in 53 (35%) of the subjects, who were elderly and had a longer PSVT history with a larger left atrial dimension and frequent PACs; however, the electrophysiological properties were similar. After a 2‐year follow‐up period 36 (24%) of the patients still exhibited PAC runs, including 13 (9%) with atrial flutter and AF, each one of whom were complicated with nonlethal cerebral thromboembolism and congestive heart failure. Multiple‐logistic‐regression analysis revealed that advanced age (≥ 41 years, P = 0.0152) and frequent PACs (≥ 1% of total daily QRS counts, P = 0.0426) on Holter monitoring are the risk factors of PAC runs and/or atrial flutter and AF. In conclusion, successful ablation for PSVT is thought to be beneficial for preventing atrial flutter and AF. However, careful follow‐up to monitor for the recurrence and atrial flutter and AF related complications, especially in patients of solitary atrial flutter and AF without reciprocating tachycardia and with frequent PAC.
Url:
DOI: 10.1046/j.1460-9592.2001.00969.x
Links to Exploration step
ISTEX:77569EB605E14391495F61D44496E72D26CA12E9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title><author><name sortKey="Miyamoto, Ken Iroh" sort="Miyamoto, Ken Iroh" uniqKey="Miyamoto K" first="Ken-Jiroh" last="Miyamoto">Ken-Jiroh Miyamoto</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tsuchihashi, Kazufumi" sort="Tsuchihashi, Kazufumi" uniqKey="Tsuchihashi K" first="Kazufumi" last="Tsuchihashi">Kazufumi Tsuchihashi</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Uno, Kikuya" sort="Uno, Kikuya" uniqKey="Uno K" first="Kikuya" last="Uno">Kikuya Uno</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Shimoshige, Shin A" sort="Shimoshige, Shin A" uniqKey="Shimoshige S" first="Shin-Ya" last="Shimoshige">Shin-Ya Shimoshige</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Yoshioka, Nobuhiro" sort="Yoshioka, Nobuhiro" uniqKey="Yoshioka N" first="Nobuhiro" last="Yoshioka">Nobuhiro Yoshioka</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Doi, Atsushi" sort="Doi, Atsushi" uniqKey="Doi A" first="Atsushi" last="Doi">Atsushi Doi</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nakata, Tomoaki" sort="Nakata, Tomoaki" uniqKey="Nakata T" first="Tomoaki" last="Nakata">Tomoaki Nakata</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Shimamoto, Kazuaki" sort="Shimamoto, Kazuaki" uniqKey="Shimamoto K" first="Kazuaki" last="Shimamoto">Kazuaki Shimamoto</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:77569EB605E14391495F61D44496E72D26CA12E9</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1046/j.1460-9592.2001.00969.x</idno><idno type="url">https://api.istex.fr/document/77569EB605E14391495F61D44496E72D26CA12E9/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000921</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title><author><name sortKey="Miyamoto, Ken Iroh" sort="Miyamoto, Ken Iroh" uniqKey="Miyamoto K" first="Ken-Jiroh" last="Miyamoto">Ken-Jiroh Miyamoto</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tsuchihashi, Kazufumi" sort="Tsuchihashi, Kazufumi" uniqKey="Tsuchihashi K" first="Kazufumi" last="Tsuchihashi">Kazufumi Tsuchihashi</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Uno, Kikuya" sort="Uno, Kikuya" uniqKey="Uno K" first="Kikuya" last="Uno">Kikuya Uno</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Shimoshige, Shin A" sort="Shimoshige, Shin A" uniqKey="Shimoshige S" first="Shin-Ya" last="Shimoshige">Shin-Ya Shimoshige</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Yoshioka, Nobuhiro" sort="Yoshioka, Nobuhiro" uniqKey="Yoshioka N" first="Nobuhiro" last="Yoshioka">Nobuhiro Yoshioka</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Doi, Atsushi" sort="Doi, Atsushi" uniqKey="Doi A" first="Atsushi" last="Doi">Atsushi Doi</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nakata, Tomoaki" sort="Nakata, Tomoaki" uniqKey="Nakata T" first="Tomoaki" last="Nakata">Tomoaki Nakata</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author><author><name sortKey="Shimamoto, Kazuaki" sort="Shimamoto, Kazuaki" uniqKey="Shimamoto K" first="Kazuaki" last="Shimamoto">Kazuaki Shimamoto</name><affiliation><mods:affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Pacing and Clinical Electrophysiology</title><idno type="ISSN">0147-8389</idno><idno type="eISSN">1540-8159</idno><imprint><publisher>Blackwell Futura Publishing, Inc.</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2001-06">2001-06</date><biblScope unit="volume">24</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="969">969</biblScope><biblScope unit="page" to="978">978</biblScope></imprint><idno type="ISSN">0147-8389</idno></series><idno type="istex">77569EB605E14391495F61D44496E72D26CA12E9</idno><idno type="DOI">10.1046/j.1460-9592.2001.00969.x</idno><idno type="ArticleID">PACE969</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0147-8389</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>WPW syndrome</term><term>atrial fibrillation</term><term>paroxysmal supraventricular tachycardia</term><term>radiofrequent ablation</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">MIYAMOTO, K.‐J., et al.: Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation. Atrial flutter and AF are complications in approximately 30% of cases of paroxysmal supraventricular tachycardia (PSVT)‐indicated catheter ablation, and it is of interest to determine if therapeutic modification for PSVT would eliminate combined atrial tachyarrhythmia like atrial flutter and AF. The aim of this study was to determine the incidence and the risk of atrial tachyarrhythmias after catheter ablation of PSVT. A total of 152 patients (age range 12–74, mean 41 ± 17 years) with accessory pathway (n = 106) and/or dual atrioventricular nodal conduction (n = 46) were enrolled in a 2‐year follow‐up program after successful catheter ablation. Possible risks on clinical background (age, sex, PSVT duration, hemodynamic instability during attacks), premature atrial contraction (PACs) on Holter monitoring, echocardiographic left atrial size, and electrophysiological property (insertion site, conduction type, effective refractory period) were evaluated. Atrial flutter and AF were complications in 53 (35%) of the subjects, who were elderly and had a longer PSVT history with a larger left atrial dimension and frequent PACs; however, the electrophysiological properties were similar. After a 2‐year follow‐up period 36 (24%) of the patients still exhibited PAC runs, including 13 (9%) with atrial flutter and AF, each one of whom were complicated with nonlethal cerebral thromboembolism and congestive heart failure. Multiple‐logistic‐regression analysis revealed that advanced age (≥ 41 years, P = 0.0152) and frequent PACs (≥ 1% of total daily QRS counts, P = 0.0426) on Holter monitoring are the risk factors of PAC runs and/or atrial flutter and AF. In conclusion, successful ablation for PSVT is thought to be beneficial for preventing atrial flutter and AF. However, careful follow‐up to monitor for the recurrence and atrial flutter and AF related complications, especially in patients of solitary atrial flutter and AF without reciprocating tachycardia and with frequent PAC.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>KEN‐JIROH MIYAMOTO</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item><json:item><name>KAZUFUMI TSUCHIHASHI</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item><json:item><name>KIKUYA UNO</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item><json:item><name>SHIN‐YA SHIMOSHIGE</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item><json:item><name>NOBUHIRO YOSHIOKA</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item><json:item><name>ATSUSHI DOI</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item><json:item><name>TOMOAKI NAKATA</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item><json:item><name>KAZUAKI SHIMAMOTO</name><affiliations><json:string>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>atrial fibrillation</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>WPW syndrome</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>paroxysmal supraventricular tachycardia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>radiofrequent ablation</value></json:item></subject><articleId><json:string>PACE969</json:string></articleId><language><json:string>eng</json:string></language><abstract>MIYAMOTO, K.‐J., et al.: Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation. Atrial flutter and AF are complications in approximately 30% of cases of paroxysmal supraventricular tachycardia (PSVT)‐indicated catheter ablation, and it is of interest to determine if therapeutic modification for PSVT would eliminate combined atrial tachyarrhythmia like atrial flutter and AF. The aim of this study was to determine the incidence and the risk of atrial tachyarrhythmias after catheter ablation of PSVT. A total of 152 patients (age range 12–74, mean 41 ± 17 years) with accessory pathway (n = 106) and/or dual atrioventricular nodal conduction (n = 46) were enrolled in a 2‐year follow‐up program after successful catheter ablation. Possible risks on clinical background (age, sex, PSVT duration, hemodynamic instability during attacks), premature atrial contraction (PACs) on Holter monitoring, echocardiographic left atrial size, and electrophysiological property (insertion site, conduction type, effective refractory period) were evaluated. Atrial flutter and AF were complications in 53 (35%) of the subjects, who were elderly and had a longer PSVT history with a larger left atrial dimension and frequent PACs; however, the electrophysiological properties were similar. After a 2‐year follow‐up period 36 (24%) of the patients still exhibited PAC runs, including 13 (9%) with atrial flutter and AF, each one of whom were complicated with nonlethal cerebral thromboembolism and congestive heart failure. Multiple‐logistic‐regression analysis revealed that advanced age (≥ 41 years, P = 0.0152) and frequent PACs (≥ 1% of total daily QRS counts, P = 0.0426) on Holter monitoring are the risk factors of PAC runs and/or atrial flutter and AF. In conclusion, successful ablation for PSVT is thought to be beneficial for preventing atrial flutter and AF. However, careful follow‐up to monitor for the recurrence and atrial flutter and AF related complications, especially in patients of solitary atrial flutter and AF without reciprocating tachycardia and with frequent PAC.</abstract><qualityIndicators><score>8</score><pdfVersion>1.2</pdfVersion><pdfPageSize>537.449 x 770.457 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>4</keywordCount><abstractCharCount>2214</abstractCharCount><pdfWordCount>5102</pdfWordCount><pdfCharCount>33022</pdfCharCount><pdfPageCount>10</pdfPageCount><abstractWordCount>322</abstractWordCount></qualityIndicators><title>Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title><genre><json:string>article</json:string></genre><host><volume>24</volume><publisherId><json:string>PACE</json:string></publisherId><pages><total>10</total><last>978</last><first>969</first></pages><issn><json:string>0147-8389</json:string></issn><issue>6</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1540-8159</json:string></eissn><title>Pacing and Clinical Electrophysiology</title><doi><json:string>10.1111/(ISSN)1540-8159</json:string></doi></host><publicationDate>2001</publicationDate><copyrightDate>2001</copyrightDate><doi><json:string>10.1046/j.1460-9592.2001.00969.x</json:string></doi><id>77569EB605E14391495F61D44496E72D26CA12E9</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/77569EB605E14391495F61D44496E72D26CA12E9/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/77569EB605E14391495F61D44496E72D26CA12E9/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/77569EB605E14391495F61D44496E72D26CA12E9/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title><respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Futura Publishing, Inc.</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>WILEY</p></availability><date>2001</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title><author><persName><forename type="first">KEN‐JIROH</forename><surname>MIYAMOTO</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author><author><persName><forename type="first">KAZUFUMI</forename><surname>TSUCHIHASHI</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author><author><persName><forename type="first">KIKUYA</forename><surname>UNO</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author><author><persName><forename type="first">SHIN‐YA</forename><surname>SHIMOSHIGE</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author><author><persName><forename type="first">NOBUHIRO</forename><surname>YOSHIOKA</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author><author><persName><forename type="first">ATSUSHI</forename><surname>DOI</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author><author><persName><forename type="first">TOMOAKI</forename><surname>NAKATA</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author><author><persName><forename type="first">KAZUAKI</forename><surname>SHIMAMOTO</surname></persName><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation></author></analytic><monogr><title level="j">Pacing and Clinical Electrophysiology</title><idno type="pISSN">0147-8389</idno><idno type="eISSN">1540-8159</idno><idno type="DOI">10.1111/(ISSN)1540-8159</idno><imprint><publisher>Blackwell Futura Publishing, Inc.</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2001-06"></date><biblScope unit="volume">24</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="969">969</biblScope><biblScope unit="page" to="978">978</biblScope></imprint></monogr><idno type="istex">77569EB605E14391495F61D44496E72D26CA12E9</idno><idno type="DOI">10.1046/j.1460-9592.2001.00969.x</idno><idno type="ArticleID">PACE969</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2001</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>MIYAMOTO, K.‐J., et al.: Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation. Atrial flutter and AF are complications in approximately 30% of cases of paroxysmal supraventricular tachycardia (PSVT)‐indicated catheter ablation, and it is of interest to determine if therapeutic modification for PSVT would eliminate combined atrial tachyarrhythmia like atrial flutter and AF. The aim of this study was to determine the incidence and the risk of atrial tachyarrhythmias after catheter ablation of PSVT. A total of 152 patients (age range 12–74, mean 41 ± 17 years) with accessory pathway (n = 106) and/or dual atrioventricular nodal conduction (n = 46) were enrolled in a 2‐year follow‐up program after successful catheter ablation. Possible risks on clinical background (age, sex, PSVT duration, hemodynamic instability during attacks), premature atrial contraction (PACs) on Holter monitoring, echocardiographic left atrial size, and electrophysiological property (insertion site, conduction type, effective refractory period) were evaluated. Atrial flutter and AF were complications in 53 (35%) of the subjects, who were elderly and had a longer PSVT history with a larger left atrial dimension and frequent PACs; however, the electrophysiological properties were similar. After a 2‐year follow‐up period 36 (24%) of the patients still exhibited PAC runs, including 13 (9%) with atrial flutter and AF, each one of whom were complicated with nonlethal cerebral thromboembolism and congestive heart failure. Multiple‐logistic‐regression analysis revealed that advanced age (≥ 41 years, P = 0.0152) and frequent PACs (≥ 1% of total daily QRS counts, P = 0.0426) on Holter monitoring are the risk factors of PAC runs and/or atrial flutter and AF. In conclusion, successful ablation for PSVT is thought to be beneficial for preventing atrial flutter and AF. However, careful follow‐up to monitor for the recurrence and atrial flutter and AF related complications, especially in patients of solitary atrial flutter and AF without reciprocating tachycardia and with frequent PAC.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>atrial fibrillation</term></item><item><term>WPW syndrome</term></item><item><term>paroxysmal supraventricular tachycardia</term></item><item><term>radiofrequent ablation</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2001-06">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-3">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/77569EB605E14391495F61D44496E72D26CA12E9/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley component found"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Futura Publishing, Inc.</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1540-8159</doi><issn type="print">0147-8389</issn><issn type="electronic">1540-8159</issn><idGroup><id type="product" value="PACE"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="PACING CLINICAL ELECTROPHYSIOLOGY">Pacing and Clinical Electrophysiology</title></titleGroup></publicationMeta><publicationMeta level="part" position="06006"><doi origin="wiley">10.1111/pace.2001.24.issue-6</doi><numberingGroup><numbering type="journalVolume" number="24">24</numbering><numbering type="journalIssue" number="6">6</numbering></numberingGroup><coverDate startDate="2001-06">June 2001</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="0096900" status="forIssue"><doi origin="wiley">10.1046/j.1460-9592.2001.00969.x</doi><idGroup><id type="unit" value="PACE969"></id></idGroup><countGroup><count type="pageTotal" number="10"></count></countGroup><copyright>© Futura Publishing Company, Inc. 2001</copyright><eventGroup><event type="firstOnline" date="2003-07-22"></event><event type="publishedOnlineFinalForm" date="2003-07-22"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:Header result:Header" date="2010-03-02"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-06"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="969">969</numbering><numbering type="pageLast" number="978">978</numbering></numberingGroup><correspondenceTo>Address for reprint: Kazufumi Tsuchihashi, M.D., Ph.D., Second Department of Internal Medicine, Sapporo Medical University School of Medicine, S‐1, W‐16, Chuo‐ku, Sapporo 060‐0061, Japan. Fax, 181‐11‐644‐7958; e‐mail: <email>tsuchiha@sapmed.ac.jp</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:PACE.PACE969.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received April 18, 2000; revised August 1, 2000; accepted October 9, 2000.</unparsedEditorialHistory><titleGroup><title type="main">Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>KEN‐JIROH</givenNames><familyName>MIYAMOTO</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>KAZUFUMI</givenNames><familyName>TSUCHIHASHI</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>KIKUYA</givenNames><familyName>UNO</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a1"><personName><givenNames>SHIN‐YA</givenNames><familyName>SHIMOSHIGE</familyName></personName></creator><creator creatorRole="author" xml:id="cr5" affiliationRef="#a2"><personName><givenNames>NOBUHIRO</givenNames><familyName>YOSHIOKA</familyName></personName></creator><creator creatorRole="author" xml:id="cr6" affiliationRef="#a1"><personName><givenNames>ATSUSHI</givenNames><familyName>DOI</familyName></personName></creator><creator creatorRole="author" xml:id="cr7" affiliationRef="#a1"><personName><givenNames>TOMOAKI</givenNames><familyName>NAKATA</familyName></personName></creator><creator creatorRole="author" xml:id="cr8" affiliationRef="#a1"><personName><givenNames>KAZUAKI</givenNames><familyName>SHIMAMOTO</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="JP"><unparsedAffiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="JP"><unparsedAffiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">atrial fibrillation</keyword><keyword xml:id="k2">WPW syndrome</keyword><keyword xml:id="k3">paroxysmal supraventricular tachycardia</keyword><keyword xml:id="k4">radiofrequent ablation</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p> <b>MIYAMOTO, K.‐J., <sc>et al.</sc>: Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation.</b> Atrial flutter and AF are complications in approximately 30% of cases of paroxysmal supraventricular tachycardia (PSVT)‐indicated catheter ablation, and it is of interest to determine if therapeutic modification for PSVT would eliminate combined atrial tachyarrhythmia like atrial flutter and AF. The aim of this study was to determine the incidence and the risk of atrial tachyarrhythmias after catheter ablation of PSVT. A total of 152 patients (age range 12–74, mean <span type="mathematics">41 ± 17</span> years) with accessory pathway (<span type="mathematics">n = 106</span>) and/or dual atrioventricular nodal conduction (<span type="mathematics">n = 46</span>) were enrolled in a 2‐year follow‐up program after successful catheter ablation. Possible risks on clinical background (age, sex, PSVT duration, hemodynamic instability during attacks), premature atrial contraction (PACs) on Holter monitoring, echocardiographic left atrial size, and electrophysiological property (insertion site, conduction type, effective refractory period) were evaluated. Atrial flutter and AF were complications in 53 (35%) of the subjects, who were elderly and had a longer PSVT history with a larger left atrial dimension and frequent PACs; however, the electrophysiological properties were similar. After a 2‐year follow‐up period 36 (24%) of the patients still exhibited PAC runs, including 13 (9%) with atrial flutter and AF, each one of whom were complicated with nonlethal cerebral thromboembolism and congestive heart failure. Multiple‐logistic‐regression analysis revealed that advanced age (≥ 41 years, <span type="mathematics">P = 0.0152</span>) and frequent PACs (≥ 1% of total daily QRS counts, <span type="mathematics">P = 0.0426</span>) on Holter monitoring are the risk factors of PAC runs and/or atrial flutter and AF. In conclusion, successful ablation for PSVT is thought to be beneficial for preventing atrial flutter and AF. However, careful follow‐up to monitor for the recurrence and atrial flutter and AF related complications, especially in patients of solitary atrial flutter and AF without reciprocating tachycardia and with frequent PAC.</p><!-- (PACE 2001; 24:969–978)
</abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation</title></titleInfo><name type="personal"><namePart type="given">KEN‐JIROH</namePart><namePart type="family">MIYAMOTO</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KAZUFUMI</namePart><namePart type="family">TSUCHIHASHI</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KIKUYA</namePart><namePart type="family">UNO</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SHIN‐YA</namePart><namePart type="family">SHIMOSHIGE</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NOBUHIRO</namePart><namePart type="family">YOSHIOKA</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ATSUSHI</namePart><namePart type="family">DOI</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TOMOAKI</namePart><namePart type="family">NAKATA</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KAZUAKI</namePart><namePart type="family">SHIMAMOTO</namePart><affiliation>Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Chuo‐ku, Sapporo, and the Department of Cardiology, Kushiro‐City General Hospital, Syunko‐dai, Kushiro‐city, Hokkaido, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Futura Publishing, Inc.</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2001-06</dateIssued><edition>Received April 18, 2000; revised August 1, 2000; accepted October 9, 2000.</edition><copyrightDate encoding="w3cdtf">2001</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">MIYAMOTO, K.‐J., et al.: Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation. Atrial flutter and AF are complications in approximately 30% of cases of paroxysmal supraventricular tachycardia (PSVT)‐indicated catheter ablation, and it is of interest to determine if therapeutic modification for PSVT would eliminate combined atrial tachyarrhythmia like atrial flutter and AF. The aim of this study was to determine the incidence and the risk of atrial tachyarrhythmias after catheter ablation of PSVT. A total of 152 patients (age range 12–74, mean 41 ± 17 years) with accessory pathway (n = 106) and/or dual atrioventricular nodal conduction (n = 46) were enrolled in a 2‐year follow‐up program after successful catheter ablation. Possible risks on clinical background (age, sex, PSVT duration, hemodynamic instability during attacks), premature atrial contraction (PACs) on Holter monitoring, echocardiographic left atrial size, and electrophysiological property (insertion site, conduction type, effective refractory period) were evaluated. Atrial flutter and AF were complications in 53 (35%) of the subjects, who were elderly and had a longer PSVT history with a larger left atrial dimension and frequent PACs; however, the electrophysiological properties were similar. After a 2‐year follow‐up period 36 (24%) of the patients still exhibited PAC runs, including 13 (9%) with atrial flutter and AF, each one of whom were complicated with nonlethal cerebral thromboembolism and congestive heart failure. Multiple‐logistic‐regression analysis revealed that advanced age (≥ 41 years, P = 0.0152) and frequent PACs (≥ 1% of total daily QRS counts, P = 0.0426) on Holter monitoring are the risk factors of PAC runs and/or atrial flutter and AF. In conclusion, successful ablation for PSVT is thought to be beneficial for preventing atrial flutter and AF. However, careful follow‐up to monitor for the recurrence and atrial flutter and AF related complications, especially in patients of solitary atrial flutter and AF without reciprocating tachycardia and with frequent PAC.</abstract><subject lang="en"><genre>Keywords</genre><topic>atrial fibrillation</topic><topic>WPW syndrome</topic><topic>paroxysmal supraventricular tachycardia</topic><topic>radiofrequent ablation</topic></subject><relatedItem type="host"><titleInfo><title>Pacing and Clinical Electrophysiology</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0147-8389</identifier><identifier type="eISSN">1540-8159</identifier><identifier type="DOI">10.1111/(ISSN)1540-8159</identifier><identifier type="PublisherID">PACE</identifier><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><detail type="issue"><caption>no.</caption><number>6</number></detail><extent unit="pages"><start>969</start><end>978</end><total>10</total></extent></part></relatedItem><identifier type="istex">77569EB605E14391495F61D44496E72D26CA12E9</identifier><identifier type="DOI">10.1046/j.1460-9592.2001.00969.x</identifier><identifier type="ArticleID">PACE969</identifier><accessCondition type="use and reproduction" contentType="copyright">© Futura Publishing Company, Inc. 2001</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Futura Publishing, Inc.</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000921 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000921 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:77569EB605E14391495F61D44496E72D26CA12E9
|texte= Studies on the Prevalence of Complicated Atrial Arrhythmias, Flutter, and Fibrillation in Patients with Reciprocating Supraventricular Tachycardia Before and After Successful Catheter Ablation
}}
| This area was generated with Dilib version V0.6.23. |  |